MAP1LC3C Repression Reduces CIITA- and HLA Class II Expression in Non-small Cell Lung Cancer

Overview

Journal PLoS One

Date 2025 Feb 10

PMID 39928678

Authors

Lydie M O Barbeau

Nicky A Beelen

Kim G Savelkouls

Tom G H Keulers

Lotte Wieten

Kasper M A Rouschop

Affiliations

Soon will be listed here.

Abstract

In the last decade, advancements in understanding the genetic landscape of lung squamous cell carcinoma (LUSC) have significantly impacted therapy development. Immune checkpoint inhibitors (ICI) have shown great promise, improving overall and progression-free survival in approximately 25% of the patients. However, challenges remain, such as the lack of predictive biomarkers, difficulties in patient stratification, and identifying mechanisms that cancers use to become immune-resistant ("immune-cold"). Analysis of TCGA datasets reveals reduced MAP1LC3C expression in cancer. Further analysis indicates that low MAP1LC3C is associated with reduced CIITA and HLA expression and with decreased immune cell infiltration. In tumor cells, silencing MAP1LC3C inhibits CIITA expression and suppresses HLA class II production. These findings suggest that cancer cells are selected for low MAP1LC3C expression to evade efficient immune responses.

References

Surmann E, Voigt A, Michel S, Bauer K, Reuschenbach M, Ferrone S . Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer. Cancer Immunol Immunother. 2014; 64(3):357-66. PMC: 8711774. DOI: 10.1007/s00262-014-1638-4. View

Klionsky D, Emr S . Autophagy as a regulated pathway of cellular degradation. Science. 2000; 290(5497):1717-21. PMC: 2732363. DOI: 10.1126/science.290.5497.1717. View

Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View

Bell E, Coelho P, Ratcliffe C, Rajadurai C, Peschard P, Vaillancourt R . LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and Invasion. Cell Rep. 2019; 29(12):4053-4068.e6. DOI: 10.1016/j.celrep.2019.11.063. View

Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T . Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science. 2004; 307(5709):593-6. DOI: 10.1126/science.1104904. View

Tumbarello D, Manna P, Allen M, Bycroft M, Arden S, Kendrick-Jones J . The Autophagy Receptor TAX1BP1 and the Molecular Motor Myosin VI Are Required for Clearance of Salmonella Typhimurium by Autophagy. PLoS Pathog. 2015; 11(10):e1005174. PMC: 4599966. DOI: 10.1371/journal.ppat.1005174. View

Kim S, Cho S . The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. Front Pharmacol. 2022; 13:868695. PMC: 9171538. DOI: 10.3389/fphar.2022.868695. View

. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012; 489(7417):519-25. PMC: 3466113. DOI: 10.1038/nature11404. View

Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W . Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019; 178(4):795-806.e12. PMC: 7288240. DOI: 10.1016/j.cell.2019.07.008. View

10.

Magner W, Kazim A, Stewart C, Romano M, Catalano G, Grande C . Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol. 2000; 165(12):7017-24. DOI: 10.4049/jimmunol.165.12.7017. View

11.

Liu G, Barczak W, Ni Lee L, Shrestha A, Provine N, Albayrak G . The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. Commun Biol. 2023; 6(1):102. PMC: 9878486. DOI: 10.1038/s42003-023-04485-y. View

12.

Gainor J, Shaw A, Sequist L, Fu X, Azzoli C, Piotrowska Z . EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis. Clin Cancer Res. 2016; 22(18):4585-93. PMC: 5026567. DOI: 10.1158/1078-0432.CCR-15-3101. View

13.

Li Y, Wang L, Yang G, Hao F, Urba W, Hu H . Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 2008; 68(17):6889-95. PMC: 2905686. DOI: 10.1158/0008-5472.CAN-08-0161. View

14.

Carinci M, Testa B, Bordi M, Milletti G, Bonora M, Antonucci L . TFG binds LC3C to regulate ULK1 localization and autophagosome formation. EMBO J. 2021; 40(10):e103563. PMC: 8126910. DOI: 10.15252/embj.2019103563. View

15.

Henke E, Nandigama R, Ergun S . Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy. Front Mol Biosci. 2020; 6:160. PMC: 7025524. DOI: 10.3389/fmolb.2019.00160. View

16.

Meazza R, Comes A, Orengo A, Ferrini S, Accolla R . Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells. Eur J Immunol. 2003; 33(5):1183-92. DOI: 10.1002/eji.200323712. View

17.

Milutinovic S, Zhuang Q, Szyf M . Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification. J Biol Chem. 2002; 277(23):20974-8. DOI: 10.1074/jbc.M202504200. View

18.

Mizushima N . The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ. 2005; 12 Suppl 2:1535-41. DOI: 10.1038/sj.cdd.4401728. View

19.

Grunstein M . Histone acetylation in chromatin structure and transcription. Nature. 1997; 389(6649):349-52. DOI: 10.1038/38664. View

20.

Madjo U, Leymarie O, Fremont S, Kuster A, Nehlich M, Gallois-Montbrun S . LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway. Cell Rep. 2016; 17(9):2221-2233. DOI: 10.1016/j.celrep.2016.10.045. View